Tokyo Tape
Sign in
← Fukuda Denshi

Quarterly report · Q2

6960.TEDINET S100S7MX
Period2023-04-01 → 2023-09-30
Filed2023-11-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥66.5bn2023-04-01 → 2023-09-30Cons.Net sales
Revenue¥134.6bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥62.6bn2022-04-01 → 2022-09-30Cons.Net sales
Operating income¥14.0bn2023-04-01 → 2023-09-30Cons.Operating income
Operating income¥11.1bn2022-04-01 → 2022-09-30Cons.Operating income
Ordinary income¥14.1bn2023-04-01 → 2023-09-30Cons.Ordinary income
Ordinary income¥25.1bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥11.7bn2022-04-01 → 2022-09-30Cons.Ordinary income
Profit before tax¥14.3bn2023-04-01 → 2023-09-30Cons.Income before income taxes
Profit before tax¥11.8bn2022-04-01 → 2022-09-30Cons.Income before income taxes
Net income (owners)¥9.8bn2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥17.3bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥8.1bn2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income¥9.8bn2023-04-01 → 2023-09-30Cons.Profit loss
Net income¥8.1bn2022-04-01 → 2022-09-30Cons.Profit loss
Total assets¥210.8bnat 2023-09-30Cons.Assets
Total assets¥206.9bnat 2023-03-31Cons.Assets
Total assets¥196.9bnat 2022-09-30Cons.Total assets (5-year summary)
Total liabilities¥39.3bnat 2023-09-30Cons.Liabilities
Total liabilities¥43.9bnat 2023-03-31Cons.Liabilities
Net assets / equity¥171.5bnat 2023-09-30Cons.Net assets
Net assets / equity¥163.0bnat 2023-03-31Cons.Net assets
Net assets / equity¥155.1bnat 2022-09-30Cons.Net assets (5-year summary)
Cash and deposits¥70.5bnat 2023-09-30Cons.Cash and deposits
Cash and deposits¥68.0bnat 2023-03-31Cons.Cash and deposits
Cash & equivalents¥67.5bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥64.9bnat 2023-03-31Cons.Cash and cash equivalents
Cash & equivalents¥63.4bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥61.0bnat 2022-03-31dCons.Cash and cash equivalents
Operating cash flow¥10.4bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥23.1bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥11.3bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥4.8bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥14.2bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥6.5bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥3.2bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥5.6bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥3.1bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥324.322023-04-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥208.782023-07-01 → 2023-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥571.252022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥268.432022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥174.152022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio81.3%at 2023-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio78.8%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio78.8%at 2022-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
jpcrp040300-q2r_E02304-000Consumables And Other Productsreportable segmentrevenue2023-04-01 → 2023-09-30¥20.5bn
jpcrp040300-q2r_E02304-000Consumables And Other Productsreportable segmentrevenue external2023-04-01 → 2023-09-30¥20.5bn
jpcrp040300-q2r_E02304-000Consumables And Other Productsreportable segmentsegment profit2023-04-01 → 2023-09-30¥4.1bn
jpcrp040300-q2r_E02304-000Medical Treatment Equipmentreportable segmentrevenue2023-04-01 → 2023-09-30¥29.3bn
jpcrp040300-q2r_E02304-000Medical Treatment Equipmentreportable segmentrevenue external2023-04-01 → 2023-09-30¥29.3bn
jpcrp040300-q2r_E02304-000Medical Treatment Equipmentreportable segmentsegment profit2023-04-01 → 2023-09-30¥6.7bn
jpcrp040300-q2r_E02304-000Patient Monitoring Equipmentreportable segmentrevenue2023-04-01 → 2023-09-30¥3.8bn
jpcrp040300-q2r_E02304-000Patient Monitoring Equipmentreportable segmentrevenue external2023-04-01 → 2023-09-30¥3.8bn
jpcrp040300-q2r_E02304-000Patient Monitoring Equipmentreportable segmentsegment profit2023-04-01 → 2023-09-30¥737m
jpcrp040300-q2r_E02304-000Physiological Diagnostic Equipmentreportable segmentrevenue2023-04-01 → 2023-09-30¥13.0bn
jpcrp040300-q2r_E02304-000Physiological Diagnostic Equipmentreportable segmentrevenue external2023-04-01 → 2023-09-30¥13.0bn
jpcrp040300-q2r_E02304-000Physiological Diagnostic Equipmentreportable segmentsegment profit2023-04-01 → 2023-09-30¥2.4bn
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-09-30¥66.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-09-30¥66.5bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-09-30¥14.0bn
jpcrp040300-q2r_E02304-000Consumables And Other Productsreportable segmentrevenue2022-04-01 → 2022-09-30¥17.1bn
jpcrp040300-q2r_E02304-000Consumables And Other Productsreportable segmentrevenue external2022-04-01 → 2022-09-30¥17.1bn
jpcrp040300-q2r_E02304-000Consumables And Other Productsreportable segmentsegment profit2022-04-01 → 2022-09-30¥2.1bn
jpcrp040300-q2r_E02304-000Medical Treatment Equipmentreportable segmentrevenue2022-04-01 → 2022-09-30¥26.9bn
jpcrp040300-q2r_E02304-000Medical Treatment Equipmentreportable segmentrevenue external2022-04-01 → 2022-09-30¥26.9bn
jpcrp040300-q2r_E02304-000Medical Treatment Equipmentreportable segmentsegment profit2022-04-01 → 2022-09-30¥6.0bn
jpcrp040300-q2r_E02304-000Patient Monitoring Equipmentreportable segmentrevenue2022-04-01 → 2022-09-30¥5.2bn
jpcrp040300-q2r_E02304-000Patient Monitoring Equipmentreportable segmentrevenue external2022-04-01 → 2022-09-30¥5.2bn
jpcrp040300-q2r_E02304-000Patient Monitoring Equipmentreportable segmentsegment profit2022-04-01 → 2022-09-30¥881m
jpcrp040300-q2r_E02304-000Physiological Diagnostic Equipmentreportable segmentrevenue2022-04-01 → 2022-09-30¥13.4bn
jpcrp040300-q2r_E02304-000Physiological Diagnostic Equipmentreportable segmentrevenue external2022-04-01 → 2022-09-30¥13.4bn
jpcrp040300-q2r_E02304-000Physiological Diagnostic Equipmentreportable segmentsegment profit2022-04-01 → 2022-09-30¥2.1bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-09-30¥62.6bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-09-30¥62.6bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-09-30¥11.1bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 520
ItemContextValueUnit
Work in processPrior1YearInstant212000000JPY
Work in processCurrentQuarterInstant357000000JPY
Raw materials and suppliesPrior1YearInstant5277000000JPY
Raw materials and suppliesCurrentQuarterInstant5555000000JPY
Other caPrior1YearInstant1562000000JPY
Other caCurrentQuarterInstant1586000000JPY
Allowance for doubtful accounts caPrior1YearInstant-5000000JPY
Allowance for doubtful accounts caCurrentQuarterInstant-7000000JPY
Current assetsPrior1YearInstant126725000000JPY
Current assetsCurrentQuarterInstant127342000000JPY
Property plant and equipmentPrior1YearInstant46826000000JPY
Property plant and equipmentCurrentQuarterInstant48587000000JPY
Intangible assetsPrior1YearInstant1617000000JPY
Intangible assetsCurrentQuarterInstant1506000000JPY
Investment securitiesPrior1YearInstant10815000000JPY
Investment securitiesCurrentQuarterInstant13417000000JPY
Other ioaPrior1YearInstant20951000000JPY
Other ioaCurrentQuarterInstant19957000000JPY
Allowance for doubtful accounts ioa by groupPrior1YearInstant-14000000JPY
Allowance for doubtful accounts ioa by groupCurrentQuarterInstant-12000000JPY
Investments and other assetsPrior1YearInstant31753000000JPY
Investments and other assetsCurrentQuarterInstant33363000000JPY
Noncurrent assetsPrior1YearInstant80197000000JPY
Noncurrent assetsCurrentQuarterInstant83456000000JPY
AssetsPrior1YearInstant206922000000JPY
AssetsCurrentQuarterInstant210798000000JPY
Notes and accounts payable tradePrior1YearInstant13743000000JPY
Notes and accounts payable tradeCurrentQuarterInstant13736000000JPY
Electronically recorded obligations operating clPrior1YearInstant5136000000JPY
Electronically recorded obligations operating clCurrentQuarterInstant4575000000JPY
Short term loans payablePrior1YearInstant1750000000JPY
Short term loans payableCurrentQuarterInstant1800000000JPY
Income taxes payablePrior1YearInstant4103000000JPY
Income taxes payableCurrentQuarterInstant3067000000JPY
Provision for product warrantiesPrior1YearInstant111000000JPY
Provision for product warrantiesCurrentQuarterInstant105000000JPY
Provision for bonusesPrior1YearInstant3953000000JPY
Provision for bonusesCurrentQuarterInstant2999000000JPY
Other provision clPrior1YearInstant546000000JPY
Other provision clCurrentQuarterInstant273000000JPY
Other clPrior1YearInstant8170000000JPY
Other clCurrentQuarterInstant6475000000JPY
Current liabilitiesPrior1YearInstant37514000000JPY
Current liabilitiesCurrentQuarterInstant33032000000JPY
Net defined benefit liabilityPrior1YearInstant2671000000JPY
Net defined benefit liabilityCurrentQuarterInstant2715000000JPY
Other provision nclPrior1YearInstant767000000JPY
Other provision nclCurrentQuarterInstant722000000JPY
Other nclPrior1YearInstant2921000000JPY
Other nclCurrentQuarterInstant2851000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-09-30pass